Kato, H.; Hagihara, M.; Asai, N.; Umemura, T.; Shibata, Y.; Hirai, J.; Yamagishi, Y.; Iwamoto, T.; Mikamo, H.
Efficacy of Trimethoprim–Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis. Antibiotics 2022, 11, 719.
https://doi.org/10.3390/antibiotics11060719
AMA Style
Kato H, Hagihara M, Asai N, Umemura T, Shibata Y, Hirai J, Yamagishi Y, Iwamoto T, Mikamo H.
Efficacy of Trimethoprim–Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis. Antibiotics. 2022; 11(6):719.
https://doi.org/10.3390/antibiotics11060719
Chicago/Turabian Style
Kato, Hideo, Mao Hagihara, Nobuhiro Asai, Takumi Umemura, Yuichi Shibata, Jun Hirai, Yuka Yamagishi, Takuya Iwamoto, and Hiroshige Mikamo.
2022. "Efficacy of Trimethoprim–Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis" Antibiotics 11, no. 6: 719.
https://doi.org/10.3390/antibiotics11060719
APA Style
Kato, H., Hagihara, M., Asai, N., Umemura, T., Shibata, Y., Hirai, J., Yamagishi, Y., Iwamoto, T., & Mikamo, H.
(2022). Efficacy of Trimethoprim–Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis. Antibiotics, 11(6), 719.
https://doi.org/10.3390/antibiotics11060719